Wockhardt stock up 10% as Zaynich achieves 96.8% efficacy in Phase III
Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...
Parkersburg News and Sentinel31m
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
cnbctv188m
Wockhardt shares hit 10% upper circuit after antibiotic Zaynich achieves 96% efficacy in Phase III clinical trial
Zaynich could play a key role in treating patients suffering from complicated urinary tract infections caused by ...
ASX Runners of the Week: Bio-Gene, Alterity, Aston & Canterbury
Gene Technology (ASX:BGT) 153pc up (from 2.8c to 7.1c)This week’s Bulls N’ Bears ASX Runner of the Week is Bio-Gene Technology, which revealed on Wednesday it scored a slice of two United States ...
NKyTribune24m
American Lung Association report says Kentucky is not doing enough to prevent smoking and vaping
By Sarah Ladd Kentucky Lantern The American Lung Association gave Kentucky mostly failing grades when it comes to preventing tobacco use — and helping people access recovery — in a 2025 report ...